A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Enhancing pediatric robotic pyeloplasty with a no-touch urothelium approach: a case series
Tekijät: Pakkasjärvi, Niklas; Jaakkola, Pyry; Ripatti, Liisi; Taskinen, Seppo
Kustantaja: Springer Science and Business Media LLC
Kustannuspaikka: LONDON
Julkaisuvuosi: 2025
Journal: BMC Urology
Tietokannassa oleva lehden nimi: BMC Urology
Lehden akronyymi: BMC UROL
Artikkelin numero: 94
Vuosikerta: 25
Numero: 1
Sivujen määrä: 4
eISSN: 1471-2490
DOI: https://doi.org/10.1186/s12894-025-01782-y
Verkko-osoite: https://doi.org/10.1186/s12894-025-01782-y
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/491888694
Background: Robotic-assisted laparoscopic surgery has advanced minimally invasive urology. However, the absence of haptic feedback may increase the risk of tissue trauma. This case series evaluates a no-touch technique in robotic-assisted pyeloplasty to minimize urothelial handling and assess its feasibility and short-term outcomes.
Methods: This retrospective case series reviewed 20 pediatric patients with ureteropelvic junction obstruction treated with robotic-assisted pyeloplasty between 2019 and 2022. In 10 cases, a no-touch urothelium approach was applied to minimize direct tissue handling. Patient selection, surgical details, perioperative outcomes, and follow-up at 6 and 12 months were documented.
Results: The no-touch approach was successfully implemented in all cases without intraoperative complications. Median console time was 98 min (IQR: 81-131). Postoperative outcomes were favorable, with significant improvement or resolution of hydronephrosis in all cases. No major complications occurred, and no anastomotic strictures were observed during follow-up.
Conclusions: The no-touch technique in robotic-assisted pyeloplasty is a feasible approach that maintains surgical efficiency while minimizing direct urothelial handling. Further studies with larger sample sizes and longer follow-up are needed to validate its potential benefits.
Trial registration: This study was approved by the Institutional Review Board of New Children's Hospital, Helsinki University Hospital (permit nr 5485), Finland.
Ladattava julkaisu This is an electronic reprint of the original article. |
Julkaisussa olevat rahoitustiedot:
Open Access funding provided by University of Helsinki (including Helsinki University Central Hospital).
No funding was received for this study.